Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study
- PMID: 26200036
- PMCID: PMC5568080
- DOI: 10.1097/JIM.0000000000000220
Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study
Abstract
Background: A single-nucleotide polymorphism in the aldosterone synthase gene (CYP11B2) promoter [-344C/T, rs1799998] has been reported to associate with cardiovascular phenotypes.
Methods: The Dallas Heart Study is a large, multiethnic cohort with a high prevalence of hypertension. We genotyped 3452 Dallas Heart Study participants for -344C/T. Generalized linear models were used to assess whether variation at -344C/T associated with plasma aldosterone concentration (PAC), systolic and diastolic blood pressure (SBP and DBP), plasma glucose (in persons with no diabetes), HOMA IR (Homeostasis Model Assessment as an Index of Insulin Resistance), and left ventricular (LV) mass indexed to height. Systolic blood pressure and DBP were significantly higher in blacks compared with whites (P < 0.001 for SBP and for DBP) and Hispanics (P < 0.001 for SBP and for DBP). Log-transformed body mass index was also significantly higher in blacks compared with whites (P < 0.001), but not Hispanics (P = 0.10). Log-transformed PAC was higher in whites compared with blacks (P < 0.001), but did not differ significantly in whites compared with Hispanics (P = 0.73). In univariate and multivariable analysis, -344C/T was not significantly associated with PAC within any ethnicity. In univariate and multivariable analysis, -344C/T was not associated with SBP or DBP within any ethnicity. After adjustment for multiple testing, univariate and multivariable analyses revealed no association between -344C/T and plasma glucose in patients with no diabetes, HOMA IR, or LV mass indexed to height.
Conclusions: We were unable to reproduce previously reported associations between -344C/T and PAC, blood pressure, plasma glucose, or LV mass. Methodological differences might explain the differences between our findings and those previously reported.
Figures

Similar articles
-
Association of echocardiographic left ventricular structure and -344C/T aldosterone synthase gene variant: A meta-analysis.J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):858-71. doi: 10.1177/1470320314535459. Epub 2014 Sep 10. J Renin Angiotensin Aldosterone Syst. 2015. PMID: 25208931
-
Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population.Clin Exp Hypertens. 2019;41(8):779-786. doi: 10.1080/10641963.2018.1557679. Epub 2018 Dec 18. Clin Exp Hypertens. 2019. PMID: 30561227 Clinical Trial.
-
The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients.Endocr Regul. 2020 Jul 1;54(3):217-226. doi: 10.2478/enr-2020-0024. Endocr Regul. 2020. PMID: 32857720
-
[The role of the -344C/T polymorphism of the aldosterone synthase gene (CYP11B2) in cardiovascular diseases].Postepy Hig Med Dosw (Online). 2007 Dec 27;61:838-47. Postepy Hig Med Dosw (Online). 2007. PMID: 18202594 Review. Polish.
-
Association of the -344T/C polymorphism in aldosterone synthase gene promoter with left ventricular structure in Chinese Han: A meta-analysis.Clin Exp Hypertens. 2017;39(6):562-569. doi: 10.1080/10641963.2017.1291660. Epub 2017 Jul 10. Clin Exp Hypertens. 2017. PMID: 28692307 Review.
Cited by
-
Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease.Biomolecules. 2021 May 20;11(5):763. doi: 10.3390/biom11050763. Biomolecules. 2021. PMID: 34065198 Free PMC article.
-
Association between Aldosterone Synthase (CYP11B2) Gene Polymorphism and Hypertension in Pashtun Ethnic Population of Khyber Pakhtunkwha, Pakistan.Genes (Basel). 2023 May 29;14(6):1184. doi: 10.3390/genes14061184. Genes (Basel). 2023. PMID: 37372364 Free PMC article.
References
-
- Barbato A, Russo P, Siani A, et al. Aldosterone synthase gene (CYP11B2) C-344 T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens. 2004;22:1895–1901. - PubMed
-
- Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32:198–204. - PubMed
-
- Davies E, Holloway CD, Ingram MC, et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension. 1999;33:703–707. - PubMed
-
- Freel EM, Ingram M, Friel EC, et al. Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study. Clin Endocrinol (Oxf) 2007;67:832–838. - PubMed
-
- Freel EM, Ingram M, Wallace AM, et al. Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects. Clin Endocrinol (Oxf) 2008;68:700–706. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources